Aim: To evaluate how pain, during and in-between dressing changes, is affected by the introduction of Mepilex® Border Lite, a wound dressing manufactured by Mölnlycke Health Care using Safetac® soft silicone adhesive technology, to the treatment of different types of paediatric wounds/skin injuries.
CHILDREN ARE frequently exposed to physical trauma which ma\ result in external or inrcmal wounding. There are a number of clinical challenge.s in relation to wound management in children. First is the pain suffered by patients, either in relation to the wounds themselves, underKing pathologies, or as a result of trauma caused by therapeutic interventions such as dressing-related procedures. Pain can lead to stress, the psychological aspects of which are just as important to manage as the pain itself. Pain4nduced stress can dela> wound healing and adversely affect patients' quality of life (Soon and Acton 2006) . It has been shown that patients experience most pain at dressing changes (HoIIinworth and Collier 2000) .
,Although analgesia and anaesthesia can be used to help reduce pain during dressing changes, these can be expensive for healthcare providers and carers, and some analgesic and anaesthetic agents are associated with undesirable side effet ts (Soon and , ^cton 200(i) . Second, due to the small size of paediatric wounds and (he difficulties associated with dressing unusually shaped wounds in awkward locations, such as wounds resulting from digit and limb injuries, clinicians need access to highly flexible and conformable dressings.
In addition to managing wound pain and overcoming the difficulties posed by the size and location of wounds, clinicians must also deal with the normal challenges of tissue viability, such as effectively controlling exúdate, preventing the ingression of foreign bodies {dirt, bacteria), and negating malodour, in a wide variety of wound types. The dressings they select must be appropriate for these multiple purposes.
According to a World Union ol ' Wound Healing Societies (2004) , the following dressing parameters should be considered to help minimise trauma and pain during dressing-related procedures: maintenance of moist wound healing, fluid handling capacity, atraumatic to the wound and skin, and low allergy^ potential.
Mepilex** Border Lite is a thin, absorbent, self-adhesive island dressing with a perforated soft silicone adhesive (Safetac®) wound contact layer that adheres readily to intact dry skin but does not stick to the surface of a moist wound and does not cause damage cm removal {White 2005). The absorbent core of the dressing consists of two layers. The first layer, a thin sheet of polyurethane foam, transports exúdate away from the wound to the second layer, a piece of non-woven fabric, which spreads the exúdate horizontally. The dressing also possesses a vapour permeable backing film through which the exúdate evaporates from the wound pad. The fluid handling system of Mepilex* Border Lite, in addition to its soft silicone adhesion layer inhibiting the lateral mo\ ement of exúdate from the wound to the surrounding skin, helps to minimise the risk of maceration (Thomas 2003) .
Mepilex'' Border Lite has been designed for situations where clinicians require a thin and highly conformable dressing for anatomical or practical purposes, and where fluid handling requirements are low, that is low exuding wounds such as leg and loot ulcers, pressure ulcers and traumatic wuunds such as blisters and skin tears. It is available in five sizes, of which the smaller ones are particularly suitable for the size and location of wounds in children.
A multi-centre, observational study was undertaken to evaluate the use of Mepilex* Border Lito on different types of paediatric wounds/skin injuries such as bums, traumatic wounds (cuts, scrapes, skin tears, abrasions, finger/toe injuries, and blisters), and surgical wounds.
Aims
The primary objective of the study was to e\aluate liow pain is affected during and in-between dressing changes by the introduction of soft silicone dressings to the treatment of different types of wounds/skin injuries in children. The secondary objectives of the evaluation were to assess: Levels of trauma. 
Methods
This multi-centre, obsenational study included inpatients and outpatients. Inclusion criteria were that the patients were < 16 years, had wounds and/or skin injuries that were deemed suitable to be dressed with Mepilex* Border Lite and for whom informed consent was given. Those patients for whom following the protocol would be difficult, or who had a kno\\Ti allergy or hypersensitivity to any of the dressing components, or had severe underlying disease that may have interfered with treatment were excluded.
Assessment
At the first consultation, baseline demographic data (age, gender, medical history) and history of the wound/skin injury were recorded. Any previously applied dressings were removed and details of the name and ty pe of the dressings were recorded ( Table 1) .
The following parameters were measured at the baseline visit and at all subsequent dressing changes:
Pain severity before dressing change. Pain severity during dressing change. Clinical signs of trauma to wound/skin injury and surrounding skin. Condition of the surrounding skin.
Percentage of viable/non-viable tissue (qualitative visual assessment). Exúdate amount (recorded usinji the standard terms of 'none', 'low', 'moderate' or 'high')/ nature (recorded as 'clear (serous)', 'yellow/ green', 'brown/blood' or 'other'. I I Presence of malodour.
Clinical signs of infection. nebridement (whether or not performed). Patient subjective symptoms.
Rating pain severity
Pain severity, before and during dressing change. was rated by the patient and the investigator on a scale from zero (no pain at all) to ten (worst pain ever). To facilitate this, a pain assessment tool, based on the Visual Analogue Scale (VAS) and the (Merkel et al 1997) .
Photographs of the wounds/skin injuries were taken to monitor their size and condition. At the final dressing change, the patients and the investigators compleled simple questionnaires to rate the dressing in terms of contormability, ease of use, ease of removal, and comfort.
Dressing regimen
The investigators selected the most appropriate size of Mepilex* Border Lite (chosen from one of the five different sizes available) and applied it to Ihe wound/skin injury. Combining this dressing with other dressings was acceptable if, in the opinion of the investigators, there was clinical Justification to do so. Investigators were allowed to cut the borders of the dressings if it was felt that this would facilitate application to tlexion points. Dressing changes were performed when Judged necessary' by the investigators at frequencies that they felt were compatible with good exúdate management.
Each patient was fotlowed for six weeks or until the woimd/skin injury had healed, whichever occurred earlier. At any point during the study, the investigators had the option of discontinuing treatment with Mepilex* Border Ute if, in their opinion, the dressing was no longer appropriate for a particular patient. Any untoward and/or unintended response that was possibly or probably related to the dressing were recorded on the case study form. 
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Statistical analysis
Descriptive statistics (mean and standard deviations) were applied to the primary and secondary objectives when quantitative data were established. A test was used to analyse the pain severity scores measured at baseline \ ersus those recorded at the subsequent dressing change (first visit).
Results
Thirty sL\ patients (boys, n=23; girls, n=i:i) with a mean age of 7.6 years (range nine days -I 5 years) with a \ariety of wound types satisfied the criteria for inclusion in Ihe sludy. Table 1 summarises the wound demographics at the baseline assessment. Various wound dressings were removed at baseline, for example, absorbent cellulose, hydrocolloid, honey gel, film and foam. During the study, one patient died (the cause of death was not related to the dressing), one patient was withdrawn (he was unable to attend the clinic for follow-up dressing changes) and five patients were withdrawTi as a result of the investigators deciding to switch to alternative dressings that they believed to be more appropriate. The data relating to the patients who did not complete the study were, however, included in the final analysis.
Pain:
The pain severity scores reported at the baseline visit were statistically significantly higher than those recorded at the first visit, that is, the first dressing change with Mepiiex* Border Lite. Mean score prior to dressing change was 2.SH at baseline and 0.88 at the first visit (p = ().()()05); mean score at dressing removal (patient evaluation) was ;i.84 at baseline and 1.34 at the first visit (p = 0.0002); mean score at dressing removal (investigator evaluation) was 2.5 at baseline and 135 at the first visit (p = O.OOii) (Figure 1) . The numbers of patients demonstrating decreases, increases and no changes in pain severity' from baseline to first visit are presented in Table 2 . .Analgesia use at initial dressing change was only required for two (6 per cent) patients. Of a total of 194 dressing changes involving Mepilex® Border Lile, analgesia was only used at iive Ci per cent) of them.
Trauma: üf the 194 dressing changes involving Mepilex® Border Lite that were evaluated, 193 (99.5 per cent) were reported to be atraumatie.
Wound healing: Within the stud> period, ^0 (56 per cent) wounds healed completely (mean 14.5 days, range four to 42 days). In terms of the ratio of viable tissue (healthy granulation/ re-epithelialisalion) tissue to non-\iable (sloughy/necrotic). wounds e>diibited a statistically significant larger proportion of viable tissue at the final \1sit (mean 99.5 per cent, SD 1.9) than at baseline (mean 91 per cent. SD 17.8) (p = 0.01).
Exúdate management: The wounds treated with Mepilex* Border Lite were typically associated with low-to-moderate levels of clear (serous), yellow/ green or brown/blood coloured. There were no reports of leakage. Malodour was reported at two of the dressinjj changes.
Peri-wound skin: The proportion of patients exhibiting healthy/intact skin around their wounds increased from 75 per cent at baseline to 92 per cent at the final visit.
Adverse reactions: Two adverse events were reported during the stud>. neither ol' which was considered by the investigators as being likely to have been related to the use of the dressing. One patient developed an eczematous rash (ihe patient concerned has a long history of eczema-related problems). Another patient experienced an aller}iic-t>pe reaction.
Overall evaluations (final visit)
hi terms of the overall pain that was experienced during the use of Mepilex® Border Lite, the patients themselves recorded mean pain severity scores of 0.2.3 prior to dressing change and 0.80 at dressing change. Patients gave a mean rating of 8.!iS out of ten for the overall performance of the dressing.
A summary of the investigators' final visit e\aluations are presented in Figure 2 . At the final visit, the investigators were asked to identif> which dressing they would choose if the\ could repeat the evaluation on each of their patients. Mepilex* Border Lite was chosen as the ideal dressing for 80 per cent of the wounds and other types of dressings with soft silicone Pain severity scores reported at the baseline visit were significantly higher than those recorded at the first visit adhesive teclinolog)" were chosen lor a further 9 per cent of the wounds.
Discussion
The primary' objective of this stud> was to evaluate how pain, during and in-between dressing changes of paediatric wounds/skin injuries, is affected by the introduction of Mepilex* Border Lite. These results demonstrate that this dressing can significant^ reduce pain severity* both before and during dressing change.
The literature review identified six articles related to children which incorporate pain severity scores (based on VAS or equivalents) relating to the use of other dressings and pain-relieving strategies: Platt et al (1996) , Gotschali et al (1998), Letouze ef al (2004) , Letouze et aT^ (2005) study involving 100 patients with a variety of wounds (acute, chronic and burns) treated with a lipidocolloid dressing, it was reported that analgesia was administered at 21 per cent of dressing changes, whereas in this stud> analgesia was used at onl> 3 per cent of dressing changes. Therefore, as well as reducing pain severity before and during dressing change, the use of Mepilex* Border Lite ma> be associated with a need for less analgesia during changes.
The most likely explanation for the reduction in pain severity scores reported after the introduction of Mepilex^ Border Lite is the fact that dressings with soft silicone adhesive Conformability, ease of use, ease of removal, patient comfort and overall experience with the dressing were rated 'good' to 'very good' technology are associated with atraumatic dressing changes and can be easily removed without causing trauma to wounds or surrounding skin (White 2005) .
. -Xs healing progresses, wound exúdate levels decrease, thereby reducing the propensity for trauma to peri-wound skin. A significant factor in managing this process is the selection ol dressings that provide the optimum environment in which wounds can progress to healing and effecti\ei> manage wound fluid. Thus, the dressing selection needs to be based on the condition of the wound and pcri-wound skin and should be adjusted to accommodate changes in these parameters. In addition to patients experiencing atraumatic dressing changes and minimal pain before and during dressing removal, their wounds demonstrated good progression to healing during treatment with Mepilex* Border LUe.
Conformability, ease of use, ease of removal, patient comfort and overall experience with the dressing were rated 'good' to 'very good' by the vast majorit> of the investigators' at final visit evaluations. Investigators commented mainly-on the physical handling of the dressing with regards to it staying in place. They were generally positive about the flexibility and conformability of the dressing when applied to wounds that were small and in awkward positions, such as the fingers and toes of small children. Figure ; í shows the dressing on an amputation wound on the filth digit demonstrating excellent conformability and flexibility. Comments also indicated that dressings were easy to appl> and remove.
A significant clinical challenge with small children is keeping the dressing in place and ¡n man> cases additional fixation was required lor dressing retention. The reasons given lor the lack of adhesion in this stud> included: patients interfering with their dressings, patients' active lifestyles exacerbating adhesion problems. and positions of the wounds making dressing adherence to skin problematic. These are issues commonly encountered in dressing wounds in children. Some investigators also indicated that the dressing could be maintained in place for several days, providing good protection against foreign material ingress.
Positive feedback from the patients and/ or their parents was also much in evidence in the case study forms. The patients gave a mean rating of 8.38 out of ten for the dressing's overall performance. Th^esponse was ospeciall> po.sitlve \^\\ rq^BfiJktcmfcrt. flexibility and nger amputation wound dressed wï Mepilexí«) Border Lite 1 ease of use. Ihcre were a number of reports of reduced distress and anxiet>, together with a reduced need for analgesia, after the introduction of Mepilex* Border Lite. One significant comment was from a parent who indicated that, during treatment with Mepilex'^ Border Lite, the heart monitor to which her infant was connected did not show the increased heart rates that had been observed during the application and removal of other dressings.
Methodological considerations
Trauma and pain associated with the removal of wound dressings is of major concern to patients and healthcare professionals. Furthermore, the trauma to the wound bed and surrounding skin that can occur with excessive dressing adhesion prolongs the duration of wounds, resulting in increased treatment costs and morbidity. Not surprisingly, many clinicians invohed in the field of wound care are becoming increasingl>' reluctant to prescribe traditional adhesive dressings.
These issues were carefully considered in designing the study protocol. While recognising the importance of comparator groups in clinical evaluations, it was felt that, for this particular study, there was no obvious candidate to evaluate alongside Mepilex* Border Lite and to have used a traditional adhesive wound dressing with the potential to cause trauma and pain would ha\e been unethical, particularly in view of the stud> population.
The size of the sample {36 participants) was deemed to be in line with other studies that have evaluated dressings and interventions in paediatric wound management.
Conclusion
This study was undertaken to evaluate the impact of introducing Mepilex"' Border Lite into the treatment regimen of children and young people with a variety of wound types. The results show that this product addresses the major challenges that clinicians face when treating such wounds, that is, the need to use dressings that are atraumatic and minimise pain on removal, and that have sufficient flexihiiity and conformabihty to sta> in place when applied to small wounds in awkward locations. Moreover, Mepilex'^ Border Lite has been shown to be capable of promoting a wound healing environment that is conducive to healing, managing low-to-moderate levels of exúdate, and preventing maceration of peri-wound skin.
